Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry

Author:

Medina C.1,Carretero G.1,Ferrandiz C.2,Dauden E.3,Vanaclocha F.4,Gómez-García F.J.5,Herrera-Ceballos E.6,De la Cueva-Dobao P.7,Belinchón I.8,Sánchez-Carazo J.L.9,Alsina M.10,López-Estebaranz J.L.11,Ferrán M.12,Carrascosa J.M.2,Torrado R.1,Argila D.3,Rivera R.4,Jiménez-Puya R.5,García-Doval I.1314,

Affiliation:

1. Hospital Universitario de Gran Canaria Dr Negrín; Las Palmas de Gran Canaria Spain

2. Hospital Universitario Germans Trias i Pujol; Badalona Spain

3. Hospital Universitario la Princesa; Madrid Spain

4. Hospital Universitario 12 de Octubre; Córdoba Spain

5. Hospital Universitario Reina Sofía; Córdoba Spain

6. Hospital Universitario Virgen de la Victoria; Málaga Spain

7. Hospital Infanta Leonor; Madrid Spain

8. Hospital General Universitario de Alicante; Alicante Spain

9. Hospital General Universitario de Valencia; Valencia Spain

10. Hospital Clinic de Barcelona; Barcelona Spain

11. Hospital Universitario Fundación Alcorcón; Madrid Spain

12. Hospital del Mar; Parc de Salut Mar; Barcelona Spain

13. Research Unit.; Fundación Academia Española de Dermatología y Venereología; Madrid Spain

14. Complexo Hospitalario Universitario de Vigo; Vigo Spain

Funder

Spanish Medicines and Health Products Agency

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Reference22 articles.

1. Global epidemiology of psoriasis: a systematic review of incidence and prevalence;Parisi;J Invest Dermatol,2013

2. Epidemiology of psoriasis;Naldi;Curr Drug Targets Inflamm Allergy,2004

3. Adverse effects of biologics: a network meta-analysis and Cochrane overview;Singh;Cochrane Database Syst Rev,2011

4. Psoriasis in the elderly: from the Medical Board of the National Psoriasis Foundation;Grozdev;J Am Acad Dermatol,2011

5. Risk of serious adverse events associated with biologic and non-biologic psoriasis systemic therapy. Patients inegible vs eligible for randomized controlled trials;García-Doval;Arch Dermatol,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3